101 related articles for article (PubMed ID: 27653943)
1. "Sense-and-Treat" DNA Nanodevice for Synergetic Destruction of Circulating Tumor Cells.
Chen N; Qin S; Yang X; Wang Q; Huang J; Wang K
ACS Appl Mater Interfaces; 2016 Oct; 8(40):26552-26558. PubMed ID: 27653943
[TBL] [Abstract][Full Text] [Related]
2. Proof of concept for inhibiting metastasis: circulating tumor cell-triggered localized release of anticancer agent via a structure-switching aptamer.
Chen N; Yang X; Wang Q; Jian L; Shi H; Qin S; Wang K; Huang J; Liu W
Chem Commun (Camb); 2016 May; 52(41):6789-92. PubMed ID: 27121864
[TBL] [Abstract][Full Text] [Related]
3. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
[TBL] [Abstract][Full Text] [Related]
4. Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro.
Dai B; Hu Y; Duan J; Yang XD
Oncotarget; 2016 Jun; 7(25):38257-38269. PubMed ID: 27203221
[TBL] [Abstract][Full Text] [Related]
5. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery.
Zhang H; Ma Y; Xie Y; An Y; Huang Y; Zhu Z; Yang CJ
Sci Rep; 2015 May; 5():10099. PubMed ID: 25959874
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F
Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433
[TBL] [Abstract][Full Text] [Related]
7. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
8. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
9. Self-Assembled DNA Nanocentipede as Multivalent Drug Carrier for Targeted Delivery.
Li W; Yang X; He L; Wang K; Wang Q; Huang J; Liu J; Wu B; Xu C
ACS Appl Mater Interfaces; 2016 Oct; 8(39):25733-25740. PubMed ID: 27622459
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment.
Wang S; Zhang C; Wang G; Cheng B; Wang Y; Chen F; Chen Y; Feng M; Xiong B
Theranostics; 2016; 6(11):1877-86. PubMed ID: 27570557
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of doxorubicin using a colorectal cancer-specific ssDNA aptamer.
Li W; Chen H; Yu M; Fang J
Anat Rec (Hoboken); 2014 Dec; 297(12):2280-8. PubMed ID: 25044297
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
Shiao YS; Chiu HH; Wu PH; Huang YF
ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-functionalized nano/micro-materials for clinical diagnosis: isolation, release and bioanalysis of circulating tumor cells.
Zhao Y; Xu D; Tan W
Integr Biol (Camb); 2017 Mar; 9(3):188-205. PubMed ID: 28144664
[TBL] [Abstract][Full Text] [Related]
14. A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.
Liu X; Wu L; Wang L; Jiang W
Talanta; 2018 Mar; 179():356-363. PubMed ID: 29310244
[TBL] [Abstract][Full Text] [Related]
15. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics.
Zamay AS; Zamay GS; Kolovskaya OS; Zamay TN; Berezovski MV
Adv Exp Med Biol; 2017; 994():67-81. PubMed ID: 28560668
[TBL] [Abstract][Full Text] [Related]
17. Enrichment and Viability Inhibition of Circulating Tumor Cells on a Dual Acid-Responsive Composite Nanofiber Film.
Wang W; Cheng Y; Li Y; Zhou H; Xu LP; Wen Y; Zhao L; Zhang X
ChemMedChem; 2017 Apr; 12(7):529-536. PubMed ID: 28229535
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
19. The application of aptamer 5TR1 in triple negative breast cancer target therapy.
Luo S; Wang S; Luo N; Chen F; Hu C; Zhang K
J Cell Biochem; 2018 Jan; 119(1):896-908. PubMed ID: 28671278
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable polymeric micelle-encapsulated doxorubicin suppresses tumor metastasis by killing circulating tumor cells.
Deng S; Wu Q; Zhao Y; Zheng X; Wu N; Pang J; Li X; Bi C; Liu X; Yang L; Liu L; Su W; Wei Y; Gong C
Nanoscale; 2015 Mar; 7(12):5270-80. PubMed ID: 25721713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
